GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (FRA:6A3A) » Definitions » Total Tax Payable

Autolus Therapeutics (FRA:6A3A) Total Tax Payable : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Total Tax Payable?

Autolus Therapeutics's Total Tax Payable for the quarter that ended in Dec. 2023 was €0.00 Mil.


Autolus Therapeutics Total Tax Payable Historical Data

The historical data trend for Autolus Therapeutics's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Total Tax Payable Chart

Autolus Therapeutics Annual Data
Trend Sep16 Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Tax Payable
Get a 7-Day Free Trial 0.35 - - - -

Autolus Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Autolus Therapeutics Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


Autolus Therapeutics Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Autolus Therapeutics's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Autolus Therapeutics (FRA:6A3A) Business Description

Traded in Other Exchanges
Address
191 Wood Lane, The MediaWorks, London, GBR, W12 7FP
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Autolus Therapeutics (FRA:6A3A) Headlines

No Headlines